Article Details
Retrieved on: 2023-01-03 10:03:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer is also initiating a phase 3 study for its influenza vaccine, making it a leader in the tripledemic. Indeed, its 2022 COVID revenue is expected ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here